Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
The division is expected to grow to over a 100-member strong team by 2022
Subscribe To Our Newsletter & Stay Updated